Advertisement

 

 

Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment.

Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment.
Author Information (click to view)

Hölsken A, Buslei R,


Hölsken A, Buslei R, (click to view)

Hölsken A, Buslei R,

Advertisement

Brain pathology (Zurich, Switzerland) 27(3) 358-363 doi 10.1111/bpa.12499
Abstract

Even though ACP is a benign tumor, treatment is challenging because of the tumor’s eloquent location. Today, with the exception of surgical intervention and irradiation, further treatment options are limited. However, ongoing molecular research in this field provides insights into the pathways involved in ACP pathogenesis and reveal a plethora of druggable targets. In the next step, appropriate models are essential to identify the most suitable and effective substances for clinical practice. Primary cell cultures in low passages provide a proper and rapid tool for initial drug potency testing. The patient-derived xenograft (PDX) model accommodates ACP complexity in that it shows respect to the preserved architecture and similar histological appearance to human tumors and therefore provides the most appropriate means for analyzing pharmacological efficacy. Nevertheless, further research is needed to understand in more detail the biological background of ACP pathogenesis, which provides the identification of the best targets in the hierarchy of signaling cascades. ACP models are also important for the continuous testing of new targeting drugs, to establish precision medicine.

Submit a Comment

Your email address will not be published. Required fields are marked *

5 + nineteen =

[ HIDE/SHOW ]